Systematic Review of Ovarian Activity and Potential for Embryo Formation and Loss during the Use of Hormonal Contraception

被引:4
|
作者
Harrison, Donna [1 ]
Buskmiller, Cara [2 ]
Chireau, Monique [4 ]
Ruppersberger, Lester A. [5 ]
Yeung, Patrick P., Jr. [3 ]
机构
[1] Amer Assoc Prolife Obstetricians & Gynecologists, POB 395, Eau Claire, MI 49111 USA
[2] St Louis Univ, Obstet & Gynecol, St Louis, MO 63103 USA
[3] St Louis Univ, Dept Obstet Gynecol & Womens Hlth, St Louis, MO 63103 USA
[4] Duke Univ, Dept Obstet & Gynecol, Obstet & Gynecol, Durham, NC USA
[5] Catholic Med Assoc, Bala Cynwyd, PA USA
来源
LINACRE QUARTERLY | 2018年 / 85卷 / 04期
关键词
Bioethics of emergency contraceptives; Contraception; Emergency contraception; Ethics of reproduction; Fertility awareness; Oral contraception; Plan B; Rape protocols; Rights of conscience;
D O I
10.1177/0024363918815611
中图分类号
R-052 [医学伦理学];
学科分类号
0101 ; 120402 ;
摘要
The purpose of this review was to determine whether there is evidence that ovulation can occur in women using hormonal contraceptives and whether these drugs might inhibit implantation. We performed a systematic review of the published English-language literature from 1990 to the present which included studies on the hormonal milieu following egg release in women using any hormonal contraceptive method. High circulating estrogens and progestins in the follicular phase appear to induce dysfunctional ovulation, where follicular rupture occurs but is followed by low or absent corpus luteum production of progesterone. Hoogland scoring of ovulatory activity may inadvertently obscure the reality of ovum release by limiting the term "ovulation" to those instances where follicular rupture is followed by production of a threshold level of luteal progesterone, sufficient to sustain fertilization, implantation, and the end point of a positive beta-human chorionic gonadotropin. However, follicular ruptures and egg release with subsequent low progesterone output have been documented in women using hormonal contraception. In the absence of specific ovulation and fertilization markers, follicular rupture should be considered the best marker for egg release and potential fertilization. Women using hormonal contraceptives may produce more eggs than previously described by established criteria; moreover, suboptimal luteal progesterone production may be more likely than previously acknowledged, which may contribute to embryo loss. This information should be included in informed consent for women who are considering the use of hormonal contraception. For this study, the authors looked at English-language research articles that focused on how hormonal birth control, such as the birth control pill, may affect very early human embryos. The authors found that abnormal ovulation, or release of an egg followed by abnormal hormone levels, may often occur in women using hormonal birth control. This may increase the number of very early human embryos who are lost before a pregnancy test becomes positive. For women who are thinking about using hormonal birth control, this is important information to consider.
引用
收藏
页码:453 / 469
页数:17
相关论文
共 50 条
  • [1] Systematic Review of Postfertilization Effects and Potential for Embryo Formation and Loss during the Use of Intrauterine Devices
    Buskmiller, Cara
    Harrison, Donna
    Ruppersberger, Lester A.
    Yeung, Patrick P., Jr.
    LINACRE QUARTERLY, 2020, 87 (01): : 60 - 77
  • [2] Ovarian function during hormonal contraception assessed by endocrine and sonographic markers: a systematic review
    D'Arpe, Stella
    Di Feliciantonio, Mara
    Candelieri, Miriam
    Franceschetti, Silvia
    Piccioni, Maria Grazia
    Bastianelli, Carlo
    REPRODUCTIVE BIOMEDICINE ONLINE, 2016, 33 (04) : 436 - 448
  • [3] Ovarian and endometrial function during hormonal contraception
    Baird, DT
    Collins, J
    Cooke, I
    Glasier, A
    Jacobs, HS
    La Vecchia, C
    Stock, G
    Vercellini, P
    Cohen, J
    Crosignani, PG
    Diczfalusy, E
    Evers, JLH
    Skouby, S
    Tarlatzis, B
    HUMAN REPRODUCTION, 2001, 16 (07) : 1527 - 1535
  • [4] Postpartum hormonal contraception use and incidence of postpartum depression: a systematic review
    Ti, Angeline
    Curtis, Kathryn M.
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2019, 24 (02): : 109 - 116
  • [5] Hormonal contraception during lactation: systematic review of randomized controlled trials
    Truitt, ST
    Fraser, AB
    Grimes, DA
    Gallo, MF
    Schulz, KF
    CONTRACEPTION, 2003, 68 (04) : 233 - 238
  • [6] Hormonal contraception in women with endometriosis: a systematic review
    Grandi, Giovanni
    Barra, Fabio
    Ferrero, Simone
    Sileo, Filomena Giulia
    Bertucci, Emma
    Napolitano, Antonella
    Facchinetti, Fabio
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2019, 24 (01): : 61 - 70
  • [7] Hormonal contraception and bone metabolism: a systematic review
    Nappi, Carmine
    Bifulco, Giuseppe
    Tommaselli, Giovanni A.
    Gargano, Virginia
    Di Carlo, Costantino
    CONTRACEPTION, 2012, 86 (06) : 606 - 621
  • [8] Safety and effectiveness of hormonal contraception for women who use opioids: A systematic review
    Ti, Angeline
    Stone, Rebecca H.
    Whiteman, Maura
    Curtis, Kathryn M.
    CONTRACEPTION, 2019, 100 (06) : 480 - 483
  • [9] Systematic Review of Hormonal Contraception and Risk of Venous Thrombosis
    Keenan, Lynn
    Kerr, Tyson
    Duane, Marguerite
    Van Gundy, Karl
    LINACRE QUARTERLY, 2018, 85 (04): : 470 - 477
  • [10] Hormonal contraception and risk of endometrial cancer: a systematic review
    Mueck, Alfred O.
    Seeger, Harald
    Rabe, Thomas
    ENDOCRINE-RELATED CANCER, 2010, 17 (04) : R263 - R271